ID
45165
Description
Principal Investigator: Andrzej Krolewski, MD, PhD, Joslin Diabetes Center, Boston, MA, USA MeSH: Diabetic Nephropathies https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000302 A collection of patients with type-2 diabetes was collected at the Joslin Diabetes Center. Patients were categorized to a group of cases with diabetic nephropathy, and a group of controls with normoalbuminuria. From these groups, 173 cases and 177 controls were randomly selected for a genome-wide association study.
Lien
Mots-clés
Versions (2)
- 25/8/22 25/8/22 - Chiara Middel
- 12/10/22 12/10/22 - Adrian Schulz
Détendeur de droits
Andrzej Krolewski, MD, PhD, Joslin Diabetes Center, Boston, MA, USA
Téléchargé le
12 de octubre de 2022
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
dbGaP phs000302 Genetic Study on Nephropathy in Type-2 Diabetes
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- Subject - Consent Information
- Subject - Sample Mapping
- The dataset contains general diabetes 2 phenotype information including participants' case/control status (case: ESRD or proteinuria or microalbuminuria and chronic kidney disease [CKD] stage 4 or 5; control: normoalbuminuria, CKD Stage 1 or 2, at least 3 years duration and HbA1c of at least 6%), hemoglobin A1c values at study begin, BMI values, age of diabetes onset and duration etc., and general demographic information.
Similar models
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- Subject - Consent Information
- Subject - Sample Mapping
- The dataset contains general diabetes 2 phenotype information including participants' case/control status (case: ESRD or proteinuria or microalbuminuria and chronic kidney disease [CKD] stage 4 or 5; control: normoalbuminuria, CKD Stage 1 or 2, at least 3 years duration and HbA1c of at least 6%), hemoglobin A1c values at study begin, BMI values, age of diabetes onset and duration etc., and general demographic information.
C2700446 (UMLS CUI [1,2])
C1828181 (UMLS CUI [2,1])
C1298908 (UMLS CUI [2,2])
C0745343 (UMLS CUI [2,3])
C1828181 (UMLS CUI [3,1])
C0205087 (UMLS CUI [3,2])
C1704686 (UMLS CUI [3,3])
C0745343 (UMLS CUI [3,4])
C0022658 (UMLS CUI [1,2])
C0009932 (UMLS CUI [1,2])
C0205307 (UMLS CUI [1,2])
C2316786 (UMLS CUI [1,2])
C0011849 (UMLS CUI [1,2])
C1698493 (UMLS CUI [1,2])
C0854078 (UMLS CUI [2,1])
C0730345 (UMLS CUI [3,1])
C2317473 (UMLS CUI [4,1])
C2316810 (UMLS CUI [4,2])